Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04679818 · ClinicalTrials.gov registry record · Phase 3
Postoperative Consequences of Intraoperative NOL Titration
A Phase 3 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 72
- Enrollment target
NCT04679818: Completed Phase 3 study, sponsored by The Cleveland Clinic.
NCT04679818 is a Phase 3 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 72 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04679818, a Phase 3 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 72 participants
- Enrollment target
Study Summary
To demonstrate that intraoperative NOL-guided titration of fentanyl improves initial recovery characteristics.
Primary Outcome
Pain scores are measured using a Verbal Response Scale (VRS) every 10 minutes in the initial hour of recovery. VRS is a scale from 0 to 10 where 0 signifies no pain and 10 signifies the worst pain ever experienced.
Interventions
- DRUG Routine opioid management
- DEVICE PMD-200 Nol-guided opioid administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2020-12-30 |
| Est. Completion | 2023-01-10 |
| Phase | Phase 3 |
What the finished NCT04679818 record still lists
NCT04679818 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Routine opioid management is the first listed.
NCT04679818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04679818 about?
NCT04679818 is a clinical study titled "Postoperative Consequences of Intraoperative NOL Titration". To demonstrate that intraoperative NOL-guided titration of fentanyl improves initial recovery characteristics.
What is the current status of trial NCT04679818?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 72 participants. The study started on 2020-12-30. Estimated completion is 2023-01-10.
What interventions are being tested in trial NCT04679818?
The interventions under investigation include: Routine opioid management (DRUG), PMD-200 Nol-guided opioid administration (DEVICE).
Who is sponsoring clinical trial NCT04679818?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04679818's enrollment target sits among peer trials
72 1780th of 2000 higher than 217 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI